Meeting High Standards
As reported earlier, last year Sanofi Pasteur and Nanolek signed a Memorandum on intentions to localize manufacture of pentavalent combined vaccine Pentaxim.
Joint project completely complies with objectives and targets of PHARMA-2020 program. Its implementation will make a significant contribution into the process of modernization of Russian Healthcare.
Sanofi Pasteur and Nanolek are implementing the project in phases in production and scientific areas, exploring systems of quality assurance and improving qualification of professionals responsible for assuring high quality standards of global biopharmaceutical industry.
Within the medical part of the project of company cooperation and Kirov region a conference was held with participation of the leading experts in the field of immunoprophylaxis, pediatrics and epidemiology. They appreciated the significance of the project both for the Kirov region, where the project implementation is ongoing, and for Russian healthcare modernization on the whole.
In 2018 full cycle production know-how transfer using Pentaxim® antigens will be completed.